↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
Kkr & Co$KKR · filed: saw revenue fall 11.0% in FY2025 to $19.5BNext year $9.7B–$49.2B sealedCheck ▾Close ▴
What Kkr & Co filed
Saw revenue fall 11.0% in FY2025 to $19.5 billion, equity 7.5% of assets, and dividend per share up 7 years running. Every figure links to the filing it came from on Kkr & Co’s card.
What the house said in advance
Revenue for the fiscal year after 2025-12-31 between $9.7B and $49.2B, an 80% range sealed on 26 Sept 2026 · receipt #451d61 · graded in public by the revenue in Kkr & Co’s next annual report.
Figures as filed with the SEC. Ranges, scores and boats are statistical descriptions of past filings, not ratings or recommendations. Reporting, not advice.
In plain words
KKR's **$5.89 billion** Integer bet isolates non-reimbursed medical infrastructure as the only healthcare subsector commanding pre-2022 premiums.
$5.89 billion
making the medical device manufacturer the single largest private…
42% premium
to Integer's thirty-day volume-weighted average and arrives as global…
27%
month-over-month in August
$1.63 billion
in trailing twelve-month revenue as of June 2024
KKR & Co. agreed to acquire Integer Holdings for $5.89 billion, making the medical device manufacturer the single largest private equity healthcare transaction in August and anchoring a sector that moved against the broader dealmaking decline. The acquisition price represents a 42% premium to Integer's thirty-day volume-weighted average and arrives as global PE deal volume fell 27% month-over-month in August.
Integer manufactures components and devices for cardiac rhythm management, neuromodulation, and vascular intervention. The company reported $1.63 billion in trailing twelve-month revenue as of June 2024, with 78% derived from non-reimbursed medical device components sold to OEMs. KKR is taking the company private at $108.50 per share in cash. Integer's management, led by CEO Joseph Flanagan, will retain equity stakes and continue operating the business post-close.
The transaction matters because it confirms three trends allocators have been tracking since second-quarter earnings. First, healthcare dealmaking is no longer correlated with broader PE activity. August saw $14.2 billion in announced healthcare PE transactions while total global PE deal value dropped below $48 billion, the lowest monthly print since February 2021. Second, KKR is deploying capital into non-discretionary medical infrastructure rather than provider services or biopharma, a shift the firm telegraphed in June when it raised $6.4 billion for its Americas Fund XIII. Third, the premium paid—42% over the thirty-day VWAP—suggests that quality medical device assets with diversified OEM exposure are commanding pre-2022 multiples even as software and consumer deals trade at steep discounts.
Integer's revenue mix is critical. The company does not rely on direct hospital reimbursement or physician adoption cycles. It sells components to Medtronic, Abbott, Boston Scientific, and other large-cap device manufacturers under multi-year supply agreements. That structure insulates Integer from the Medicare Advantage rate cuts and hospital margin compression that have destroyed value in provider-services deals over the past eighteen months. KKR is effectively buying a toll bridge on the medical device supply chain, not a bet on procedure volume or coding changes.
Operators should watch three follow-on events. First, whether KKR consolidates Integer with its existing medtech portfolio companies—the firm holds stakes in Agiliti, a medical equipment services provider, and LivaNova, a cardiac surgery device maker. Consolidation would signal a build strategy rather than a standalone operational improvement play. Second, whether competing buyout shops respond by bidding for the remaining publicly traded medical device component manufacturers, a universe of roughly $22 billion in market cap across six names. Third, whether Integer's $1.1 billion debt package, expected to price in October, tightens spreads for healthcare leveraged loans. The last comparable deal, Carlyle's acquisition of Medline Industries in 2021, repriced its term loan 75 basis points tighter within ninety days.
The transaction is expected to close in the fourth quarter of 2024, subject to shareholder approval and regulatory clearance. Integer's board unanimously approved the deal. No financing condition exists; KKR is funding the purchase with committed equity and debt from Barclays, Goldman Sachs, and Morgan Stanley.
Branded by POPS4 · proof in 60 seconds
For the principal
Consider direct LP exposure to KKR's healthcare infrastructure vehicles; this premium signals durable moats in OEM supply chains.
For the operator
Track Integer's debt pricing in October; a tight spread confirms healthcare component manufacturers as the new defensive growth vertical.
For the house
Named accounts: rotate 4% from software secondaries into healthcare equipment co-invests; initiate diligence on remaining public component manufacturers.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.